Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Hepatitis A and hepatitis B infection prevalence and associated risk factors in men who have sex with men, Bangkok, 2006-2008.

Linkins RW, Chonwattana W, Holtz TH, Wasinrapee P, Chaikummao S, Varangrat A, Tongtoyai J, Mock PA, Curlin ME, Sirivongrangson P, van Griensven F, McNicholl JM.

J Med Virol. 2013 Sep;85(9):1499-505. doi: 10.1002/jmv.23637. Epub 2013 Jun 24.

PMID:
23797893
2.

Hepatitis A and B infection and vaccination in a cohort of homosexual men in Sydney.

Jin F, Prestage GP, Pell CM, Donovan B, Van de Ven PG, Kippax SC, Kaldor JM, Grulich AE.

Sex Health. 2004;1(4):227-37.

PMID:
16342422
3.

Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.

Gutiérrez Domingo I, Pascasio Acevedo JM, Alcalde Vargas A, Ramos Cuadra A, Ferrer Ríos MT, Sousa Martín JM, Sayago Mota M, Giráldez Gallego A, Suárez Artacho G.

Transplant Proc. 2012 Jul-Aug;44(6):1502-4. doi: 10.1016/j.transproceed.2012.05.020.

PMID:
22841196
4.

Prevalence and factors associated with hepatitis B immunization and infection among men who have sex with men in Beijing, China.

Wang C, Wang Y, Huang X, Li X, Zhang T, Song M, Wu L, Du J, Lu X, Shao S, Zhao F, Ball MA, Wu H, Wang W.

PLoS One. 2012;7(10):e48219. doi: 10.1371/journal.pone.0048219. Epub 2012 Oct 25.

5.

Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination.

Winnock M, Bani-Sadr F, Pambrun E, Loko MA, Lascoux-Combe C, Garipuy D, Rosenthal E, Carrieri P, Dabis F, Salmon D.

Vaccine. 2011 Nov 3;29(47):8656-60. doi: 10.1016/j.vaccine.2011.08.125. Epub 2011 Sep 13.

PMID:
21920402
7.

[Prevalence of hepatitis virus infection markers in HIV-infected patients in Southern Spain].

Cifuentes C, Mira JA, Vargas J, Neukam K, Escassi C, García-Rey S, Gilabert I, González-Monclova M, Bernal S, Pineda JA.

Enferm Infecc Microbiol Clin. 2012 Oct;30(8):452-7. doi: 10.1016/j.eimc.2011.12.008. Epub 2012 Apr 27. Spanish.

PMID:
22541340
8.

[Prevalence of infection by hepatitis viruses in a rural area. Analysis according to risk factors and alcohol consumption].

Nalpas B, Zylberberg H, Dubois F, Presles MA, Gillant JC, Lienard M, Delemotte B, Bréchot C.

Gastroenterol Clin Biol. 2000 May;24(5):536-40. French.

9.

Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection.

Collier MG, Drobeniuc J, Cuevas-Mota J, Garfein RS, Kamili S, Teshale EH.

Vaccine. 2015 Jun 4;33(24):2808-12. doi: 10.1016/j.vaccine.2015.04.019. Epub 2015 Apr 15.

PMID:
25889161
10.

A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.

Removille N, Origer A, Couffignal S, Vaillant M, Schmit JC, Lair ML.

BMC Public Health. 2011 May 19;11:351. doi: 10.1186/1471-2458-11-351.

11.

Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.

Shapiro AJ, Esther CR, Leigh MW, Dellon EP.

Vaccine. 2013 Jan 30;31(6):906-11. doi: 10.1016/j.vaccine.2012.12.004. Epub 2012 Dec 20.

PMID:
23261047
12.

Viral hepatitis among young men who have sex with men: prevalence of infection, risk behaviors, and vaccination.

Diamond C, Thiede H, Perdue T, Secura GM, Valleroy L, Mackellar D, Corey L; Seattle Young Men's Survey Team.

Sex Transm Dis. 2003 May;30(5):425-32.

PMID:
12916134
13.

Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.

Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T.

Am J Gastroenterol. 2008 Jan;103(1):138-46. Epub 2007 Oct 26.

PMID:
17970833
14.

 HAV and HBV seroprevalence in 1,000 patients with chronic HCV infection in a Tertiary Care Center in São Paulo, Brazil.

da Silva EF, Mazo DF, Oliveira CP, Medeiros RP, Carrilho FJ, Pessôa MG.

Ann Hepatol. 2016 Sep-Oct;15(5):691-5. doi: 10.5604/16652681.1212320.

15.

Seroprevalence and risk factors for hepatitis A, B, and C among Roma and non-Roma children in a deprived area of Athens, Greece.

Michos A, Terzidis A, Kalampoki V, Pantelakis K, Spanos T, Petridou ET.

J Med Virol. 2008 May;80(5):791-7. doi: 10.1002/jmv.21134.

PMID:
18360892
16.

Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage.

Gilson RJ, de Ruiter A, Waite J, Ross E, Loveday C, Howell DR, Tedder RS, Weller IV.

Sex Transm Infect. 1998 Apr;74(2):110-5.

17.

Factors associated with hepatitis B vaccination among men having sexual relations with men in Montreal, Quebec, Canada. Omega Study Group.

Dufour A, Remis RS, Alary M, Otis J, Mâsse B, Turmel B, Vincelette J, Lavoie R, LeClerc R, Parent R.

Sex Transm Dis. 1999 Jul;26(6):317-24.

PMID:
10417018
18.

Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers, and anti-hepatitis C antibodies among immigrants from the former USSR who arrived in Israel during 1990-1991.

Almog R, Low M, Cohen D, Robin G, Ashkenazi S, Bercovier H, Gdalevich M, Samuels Y, Ashkenazi I, Shemer J, Eldad A, Green MS.

Infection. 1999 May-Jun;27(3):212-7.

PMID:
10378135
19.

Prevalence of hepatitis A, B and C serological markers in children from western Mexico.

Escobedo-Meléndez G, Fierro NA, Roman S, Maldonado-González M, Zepeda-Carrillo E, Panduro A.

Ann Hepatol. 2012 Mar-Apr;11(2):194-201.

20.

Supplemental Content

Support Center